Home/Synlab/Mathieu Floreani
MF

Mathieu Floreani

Chief Executive Officer (CEO)

Synlab

Synlab Pipeline

DrugIndicationPhase
Advanced Molecular DiagnosticsOncology, Genetics, Infectious DiseasesCommercial Roll-out
Personalized & Preventive Health ProfilesWellness & Disease PreventionCommercial Expansion
Chronic Kidney Disease (CKD) ManagementNephrologyService Enhancement
Stockholm Region ContractPublic Health Service ExpansionImplementation
Emerging Market ExpansionGeographic GrowthMarket Development
ESG & Sustainable DiagnosticsCorporate StrategyOngoing Initiative